Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Myc-induced glutaminolysis bypasses HIF-driven glycolysis in hypoxic small cell lung carcinoma cells

Author:
  • Matilda Munksgaard Thorén
  • Marica Vaapil
  • Johan Staaf
  • Maria Planck
  • Martin E Johansson
  • Sofie Mohlin
  • Sven Påhlman
Publishing year: 2017-04-06
Language: English
Pages: 48983-48995
Publication/Series: Oncotarget
Volume: 8
Issue: 30
Document type: Journal article
Publisher: Impact Journals, LLC

Abstract english

We previously demonstrated that small cell lung carcinoma (SCLC) cells lack HIF-2α protein expression, whereas HIF-1α in these cells is expressed at both acute and prolonged hypoxia. Here we show that low HIF2A expression correlates with high expression of MYC genes. Knockdown of HIF1A expression had no or limited effect on cell survival and growth in vitro. Unexpectedly, hypoxic ATP levels were not affected by HIF-1α knockdown and SCLC cell viability did not decrease upon glucose deprivation. In line with these in vitro data, xenograft tumor-take and growth were not significantly affected by repressed HIF1A expression. Glutamine withdrawal drastically decreased SCLC cell proliferation and increased cell death at normoxia and hypoxia in a HIF-independent fashion and the dependence on glutaminolysis was linked to amplification of either MYC or MYCL. Downregulation of GLS expression, regulating the first step of the glutaminolysis pathway, in MYC/MYCL overexpressing SCLC cells resulted in both impaired growth and increased cell death. Our results suggest that MYC/MYCL overexpression in SCLC cells overrides the need of HIF-1 activity in response to hypoxia by inducing glutaminolysis and lipogenesis. Targeting the glutaminolysis pathway might hence be a novel approach to selectively kill MYC amplified SCLC cells in vivo.

Keywords

  • Cancer and Oncology
  • Journal Article

Other

Published
  • Clinical pathology, Malmö
  • ISSN: 1949-2553
Sven Påhlman
E-mail: sven [dot] pahlman [at] med [dot] lu [dot] se

Professor

Division of Translational Cancer Research

+46 46 222 64 21

MV406 312K1

90